- Home
- SHIM vs IMA Comparison
SHIM vs IMA Comparison
Compare SHIM & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHIM
- IMA
- Stock Information
- Founded
- SHIM 1990
- IMA 2019
- Country
- SHIM United States
- IMA United States
- Employees
- SHIM N/A
- IMA N/A
- Industry
- SHIM
- IMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SHIM
- IMA Health Care
- Exchange
- SHIM Nasdaq
- IMA Nasdaq
- Market Cap
- SHIM 97.5M
- IMA 92.2M
- IPO Year
- SHIM 2023
- IMA N/A
- Fundamental
- Price
- SHIM $2.34
- IMA $8.40
- Analyst Decision
- SHIM
- IMA Buy
- Analyst Count
- SHIM 0
- IMA 1
- Target Price
- SHIM N/A
- IMA $30.00
- AVG Volume (30 Days)
- SHIM 13.0K
- IMA 99.7K
- Earning Date
- SHIM 11-14-2025
- IMA 11-15-2025
- Dividend Yield
- SHIM N/A
- IMA N/A
- EPS Growth
- SHIM N/A
- IMA N/A
- EPS
- SHIM N/A
- IMA N/A
- Revenue
- SHIM $520,100,000.00
- IMA $4,300,000.00
- Revenue This Year
- SHIM $5.42
- IMA N/A
- Revenue Next Year
- SHIM $6.67
- IMA N/A
- P/E Ratio
- SHIM N/A
- IMA N/A
- Revenue Growth
- SHIM N/A
- IMA N/A
- 52 Week Low
- SHIM $1.30
- IMA $7.24
- 52 Week High
- SHIM $3.78
- IMA $23.28
- Technical
- Relative Strength Index (RSI)
- SHIM 39.77
- IMA N/A
- Support Level
- SHIM $2.12
- IMA N/A
- Resistance Level
- SHIM $2.39
- IMA N/A
- Average True Range (ATR)
- SHIM 0.13
- IMA 0.00
- MACD
- SHIM -0.01
- IMA 0.00
- Stochastic Oscillator
- SHIM 49.21
- IMA 0.00
About SHIM Shimmick Corporation
Shimmick Corp is a provider of water and other critical infrastructure solutions nationwide. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure, including desalination plants. In water resources projects company builds, expands, and improves water storage and conveyance, dams, levees, flood control systems, pump stations, and coastal protection. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains its nation's critical infrastructure, including mass transit, bridges, and military infrastructure.
About IMA ImageneBio Inc. Common Stock
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.